m+Medelevator.RU
← Поиск публикаций
BMC psychiatry · 2026

Neuropsychobiological transdiagnostic risk mechanisms for aggression in mental disorders across the life span.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Habel Ute, Reif Andreas, Herpertz Sabine, Konrad Kerstin, Freitag Christine, Banaschewski Tobias, Frodl Thomas, Barnes-Scheufler Catherine, Berg Lisa, Bertsch Katja, Chechko Natalya, Chiocchetti Andreas G, Ecker Christine, Ende Gabriele, Fritsch Antonia, Gramegna Chiara, Hanke Michael, Holz Nathalie, Hüpen Philippa, Kuschel Ina, Mathiak Klaus, Maas Annika, Meyer-Lindenberg Andreas, Neukel Corinne, Paret Christian, Plichta Michael, Reindl Vanessa, Retz Wolfgang, Scharf Jaqueline, Schmahl Christian, Schirok Henry, Tost Heike, Turner Daniel, Tüscher Oliver, Wagels Lisa, Weidler Carmen, Zweerings Jana

Аннотация

BACKGROUND: Aggression in mental disorders (AMD) is a prevalent symptom, poses difficulties to the clinical setting and has far-reaching societal implications. The biological basis of different manifestations, developmental courses, and disease-specific mechanisms remains largely unknown. The lack of understanding of the complex mechanisms underlying AMD due to the heterogeneity of aggression and psychiatric disorders themselves, will be addressed by studying a longitudinal transdiagnostic cohort of patients suffering from mental disorders dimensionally quantified with respect to aggressive behavior.

METHODS: Capitalizing on the Research Domain Criteria "negative valence system" (NVS) and "cognitive system" (CS), multilevel measurements of behavioral and biological systems provide a harmonized dataset at three study sites (Frankfurt, Mannheim/Heidelberg, Aachen; 900 adults, 200 children/youth) including forensic satellites (n = 150). A cross-sectional matched control group (300 adults, 100 youth) will also be included.

DISCUSSION: The goal of the study is to provide a multilevel characterization of patients, assessing dimensional phenotypic measures across time points and diagnoses, to finally define aggressive biosignatures.

TRIAL REGISTRATION: The present study has been registered at https://drks.de/register/en/trial/DRKS00035731 (number of registration: DRKS00035731; date of registration: 20/02/2025).

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты